Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced an oral presentation will be featured at the upcoming ...
CN Bio, a leading Organ-on-a-chip (OOC) company de-risking drug discovery and development pipelines by enabling earlier, more ...
Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient ou ...
Motivista is a prescription digital therapeutic indicated for the treatment of negative symptoms of schizophrenia as an ...
WO 2026/178627 covers methods, uses and compositions pairing Streptococcus salivarius SALI-10 with sorbitol, creating a ...
Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral ...
The incidence of melanoma is steadily rising, with annual cases projected to increase by more than 50% between 2020 and 2040.
FDA clearance of its Investigational New Drug (IND) application for MC001, the Company's first-in-class dimeric ...
Dr. Meltzer joins Avilar as the company advances its lead ATAC program toward the clinic. The program is an ATAC designed to ...
Privo Technologies today announced results from the CLN-004 Phase 2 (Cohort 1) trial evaluating PRV111, a nanoengineered, ...
UPPSALA, SE / ACCESS Newswire / October 5, 2026 / Senzime (STO:SEZI)(OTCQX:SNZZF) - "We reaffirm our target of reaching ...
Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, is proud to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results